πŸ‡ΊπŸ‡Έ FDA
Patent

US 7462743

Polymorphs of memantine hydrochloride

granted A61PA61P25/16

Quick answer

US patent 7462743 (Polymorphs of memantine hydrochloride) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Pharmaceutical Fine Chemicals S.R.L.
Grant date
Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P25/16